Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
Product/Service Approvals
First Pill for Postpartum Depression Is Approved by FDA
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a...
Biogen Buying Rare-Disease Drugmaker in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
Deadly Fungi Are Becoming More Common And We’re Running Out of Ways to Treat Them
Research suggests fungicides are weakening antifungals before they are up for approval. Source link
FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
HealthIn temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved...
FDA Approves GSK’s RSV Vaccine for Older Adults
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
Drug to Prevent Preterm Births to Be Pulled From Market
BusinessHealth CareHealthCovis Pharma, the maker of Makena, is planning the withdrawal after a study failed to confirm the drug works...
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults
The company said it would apply in coming months for U.S. regulatory approval. Source link
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
HealthMedicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy Source link
Elon Musk Says Neuralink Should Be Ready for Human Testing in Six Months
The neuroscience startup also showcased “telepathic typing” in a monkey with a brain implant along with other capabilities in a...
Amylyx Prices Newly Approved ALS Drug at $12,500 a Month
The drug, called Relyvrio, was approved by the Food and Drug Administration late Thursday after some staff had raised questions...
Abbott Faces Competition From Heart Valve Device Cleared by FDA
A new heart valve repair device from Edwards Lifesciences Corp. was as effective as the market-leading device from Abbott Laboratories...
Covid-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon
U.S. health regulators cleared use of retooled Covid-19 vaccines that target the latest versions of Omicron, in preparation for a...
U.K. Approves Covid-19 Booster Shot Aimed at Omicron
The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster shot, paving the way...
Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics
Pfizer Inc. has agreed to buy Global Blood Therapeutics Inc. for $5.4 billion, in a deal that would give the...
Americans With ALS Look to Canada for Promising Drug the U.S. Hasn’t Approved
Canada approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis last week. Now some U.S. patients with the fatal...
